[ad_1] Glenmark Pharmaceuticals Ltd on Friday (February 14) reported a net profit of ₹347.9 crore for Q3FY25, recovering from a net loss of ₹351.3 crore. Company Value Change %Change Revenue from operations surged 35.1% to ₹3,387.6 crore against ₹2,506.7 crore in the corresponding period of the preceding fiscal. At the operating level, EBITDA zoomed to […]
Glenmark Pharmaceuticals gets ₹121.25 crore GST demand, plans to appeal – CNBC TV18
[ad_1] Drug firm Glenmark Pharmaceuticals Ltd on Friday (February 7) said it has received an order from the Joint Commissioner of Central Goods and Services Tax and Central Excise (CGST & CX) Palghar, Maharashtra, seeking ₹121.25 crore in tax, interest, and penalties from 2017-18 to 2021-22. Company Value Change %Change The order includes a demand […]
Glenmark Pharma Aurangabad unit clears FDA test – CNBC TV18
[ad_1] Drug firm Glenmark Pharmaceuticals Ltd on Friday (September 20) said its formulation manufacturing facility in Chhatrapati Sambhaji Nagar (Aurangabad), has successfully completed a routine inspection by the US Food and Drug Administration (FDA). “This is to inform you that the U.S. FDA has issued Form 483 with zero observations after an inspection at the […]